|
US5446090A
(en)
|
1993-11-12 |
1995-08-29 |
Shearwater Polymers, Inc. |
Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
|
|
EP0958305B1
(en)
|
1996-07-05 |
2008-06-04 |
Cancer Research Technology Limited |
Inhibitions of the interaction between p53 and mdm2
|
|
US20020064546A1
(en)
|
1996-09-13 |
2002-05-30 |
J. Milton Harris |
Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor
|
|
PT1053019E
(pt)
|
1998-01-07 |
2004-04-30 |
Debio Rech Pharma Sa |
Acrilatos de poli(etileno-glicol) heterobifuncional degradaveis e geles e conjugados derivados dos mesmos
|
|
US7192713B1
(en)
|
1999-05-18 |
2007-03-20 |
President And Fellows Of Harvard College |
Stabilized compounds having secondary structure motifs
|
|
US6348558B1
(en)
|
1999-12-10 |
2002-02-19 |
Shearwater Corporation |
Hydrolytically degradable polymers and hydrogels made therefrom
|
|
BR0001870B1
(pt)
|
2000-05-29 |
2014-02-25 |
|
Peptídeo, processo de obtenção de peptídeo, formulação compreendendo peptídeo, método de prevenção de crescimento de parasitas, fungos e bactérias, método para inativar a endotoxina de bactérias gram-negativas
|
|
ES2586387T3
(es)
|
2003-11-05 |
2016-10-14 |
Dana-Farber Cancer Institute, Inc. |
Péptidos alfa helicoidales adecuados para activar o inhibir la muerte celular
|
|
US8937154B2
(en)
|
2006-10-05 |
2015-01-20 |
New York Blood Center, Inc. |
Stabilized therapeutic small helical antiviral peptides
|
|
DK2118123T3
(en)
|
2007-01-31 |
2016-01-25 |
Dana Farber Cancer Inst Inc |
Stabilized p53 peptides and uses thereof
|
|
ES2649941T3
(es)
|
2007-02-23 |
2018-01-16 |
Aileron Therapeutics, Inc. |
Aminoácidos sustituidos para preparar péptidos macrocíclicos unidos a triazol
|
|
US8592377B2
(en)
|
2007-03-28 |
2013-11-26 |
President And Fellows Of Harvard College |
Stitched polypeptides
|
|
CA2700925C
(en)
|
2007-09-26 |
2016-08-23 |
Dana Farber Cancer Institute |
Methods and compositions for modulating bcl-2 family polypeptides
|
|
GB0804701D0
(en)
|
2008-03-13 |
2008-04-16 |
Amura Therapeutics Ltd |
Compounds
|
|
WO2009137532A1
(en)
|
2008-05-06 |
2009-11-12 |
New York Blood Center |
Antiviral cell penetrating peptides
|
|
EP2356139A4
(en)
|
2008-07-23 |
2013-01-09 |
Harvard College |
LIGURE COMBINED POLYPEPTIDES
|
|
US8586707B2
(en)
|
2008-09-16 |
2013-11-19 |
The Research Foundation Of State University Of New York |
Stapled peptides and method of synthesis
|
|
CA2737922A1
(en)
|
2008-09-22 |
2010-03-25 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
BRPI0920899A2
(pt)
|
2008-11-24 |
2016-04-26 |
Aileron Therapeutics Inc |
macrociclos peptidomiméticos com propriedades melhoradas
|
|
EP3549951A3
(en)
|
2008-12-09 |
2019-11-20 |
Dana Farber Cancer Institute, Inc. |
Methods and compositions for specific modulation of mcl-1
|
|
US9175047B2
(en)
|
2009-01-14 |
2015-11-03 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
AU2010263056B2
(en)
|
2009-06-18 |
2016-01-07 |
Dana Farber Cancer Institute, Inc. |
Structured viral peptide compositions and methods of use
|
|
AU2010273220B2
(en)
|
2009-07-13 |
2015-10-15 |
President And Fellows Of Harvard College |
Bifunctional stapled polypeptides and uses thereof
|
|
WO2011072246A2
(en)
|
2009-12-10 |
2011-06-16 |
Regents Of The University Of Minnesota |
Tal effector-mediated dna modification
|
|
US9227995B2
(en)
|
2010-04-23 |
2016-01-05 |
Øyvind Jacobsen |
Peptides
|
|
WO2011156524A2
(en)
|
2010-06-08 |
2011-12-15 |
Laura Sheard |
Methods and compositions for targeted protein degradation
|
|
CN103153335A
(zh)
|
2010-06-30 |
2013-06-12 |
布兰代斯大学 |
小分子靶定的蛋白质降解
|
|
EP2590997B1
(en)
|
2010-07-09 |
2018-04-04 |
Dana-Farber Cancer Institute, Inc. |
Stabilized insulinotropic peptides and methods of use
|
|
ES2711526T3
(es)
|
2010-08-13 |
2019-05-06 |
Aileron Therapeutics Inc |
Macrociclos peptidomiméticos
|
|
WO2012040459A2
(en)
|
2010-09-22 |
2012-03-29 |
President And Fellows Of Harvard College |
Beta-catenin targeting peptides and uses thereof
|
|
CA2817568A1
(en)
|
2010-11-12 |
2012-05-18 |
The Salk Institute For Biological Studies Intellectual Property And Tech Nology Transfer |
Cancer therapies and diagnostics
|
|
CA2823837A1
(en)
|
2010-12-07 |
2012-06-14 |
Yale University |
Small-molecule hydrophobic tagging of fusion proteins and induced degradation of same
|
|
US8762795B2
(en)
|
2010-12-17 |
2014-06-24 |
Microsoft Corporation |
Alerting recipients to errors occurring when accessing external services
|
|
US9517252B2
(en)
|
2011-09-09 |
2016-12-13 |
Agency For Science, Technology And Research |
p53 activating peptides
|
|
TW201806968A
(zh)
|
2011-10-18 |
2018-03-01 |
艾利倫治療公司 |
擬肽巨環化合物
|
|
US9346868B2
(en)
|
2011-11-14 |
2016-05-24 |
Carlos Witte-Hoffmann |
BLID; a novel protein domain for interaction with the Bcl-2 family of proteins. Applications in oncology
|
|
US9408885B2
(en)
|
2011-12-01 |
2016-08-09 |
Vib Vzw |
Combinations of therapeutic agents for treating melanoma
|
|
US9464125B2
(en)
|
2012-02-03 |
2016-10-11 |
The Trustees Of Princeton University |
Engineered potent cytotoxic stapled BH3 peptides
|
|
BR112014020103A2
(pt)
|
2012-02-15 |
2018-10-09 |
Aileron Therapeutics, Inc. |
macrociclos peptidomiméticos
|
|
WO2013173755A1
(en)
|
2012-05-18 |
2013-11-21 |
The Regents Of The University Of California |
Modification of peptides using a bis(thioether)arylbridge approach
|
|
WO2014052647A2
(en)
|
2012-09-26 |
2014-04-03 |
President And Fellows Of Harvard College |
Proline-locked stapled peptides and uses thereof
|
|
WO2014053879A1
(en)
|
2012-10-04 |
2014-04-10 |
Centre National De La Recherche Scientifique |
Cell penetrating peptides for intracellular delivery of molecules
|
|
WO2014053881A1
(en)
|
2012-10-04 |
2014-04-10 |
Centre National De La Recherche Scientifique |
Cell penetrating peptides for intracellular delivery of molecules
|
|
KR101616603B1
(ko)
|
2012-10-11 |
2016-04-28 |
서울대학교산학협력단 |
메틸 데그론 펩타이드 및 이를 이용한 단백질 수명 조절 방법
|
|
EP2840140B2
(en)
|
2012-12-12 |
2023-02-22 |
The Broad Institute, Inc. |
Crispr-Cas based method for mutation of prokaryotic cells
|
|
US9783490B2
(en)
|
2012-12-18 |
2017-10-10 |
The Secretary Of State For Health |
Antimicrobial compounds, their synthesis and applications thereof
|
|
WO2014110420A1
(en)
|
2013-01-10 |
2014-07-17 |
Noliva Therapeutics Llc |
Peptidomimetic compounds
|
|
US9115184B2
(en)
|
2013-03-01 |
2015-08-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Light-inducible system for regulating protein stability
|
|
US9234213B2
(en)
|
2013-03-15 |
2016-01-12 |
System Biosciences, Llc |
Compositions and methods directed to CRISPR/Cas genomic engineering systems
|
|
JP6549554B2
(ja)
|
2013-03-15 |
2019-07-24 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
コレステロール流出を刺激する、減少した毒性を有するペプチド
|
|
US20160244494A1
(en)
|
2013-10-01 |
2016-08-25 |
President And Fellows Of Harvard College |
Stabilized polypeptides and uses thereof
|
|
CN106459995B
(zh)
|
2013-11-07 |
2020-02-21 |
爱迪塔斯医药有限公司 |
使用统治型gRNA的CRISPR相关方法和组合物
|
|
US20150165054A1
(en)
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting caspase-9 point mutations
|
|
US10682388B2
(en)
|
2014-01-15 |
2020-06-16 |
The Board Of Regents Of The University Of Texas System |
Targeting of PELP1 in cancer therapy
|
|
US10040780B2
(en)
|
2014-03-03 |
2018-08-07 |
The Regents Of The University Of California |
Mcl-1 antagonists
|
|
WO2015175642A2
(en)
|
2014-05-13 |
2015-11-19 |
Sangamo Biosciences, Inc. |
Methods and compositions for prevention or treatment of a disease
|
|
CA2949535C
(en)
|
2014-05-21 |
2023-09-12 |
President And Fellows Of Harvard College |
Ras inhibitory peptides and uses thereof
|
|
WO2016019144A2
(en)
|
2014-07-30 |
2016-02-04 |
Sangamo Biosciences, Inc. |
Gene correction of scid-related genes in hematopoietic stem and progenitor cells
|
|
US9816080B2
(en)
|
2014-10-31 |
2017-11-14 |
President And Fellows Of Harvard College |
Delivery of CAS9 via ARRDC1-mediated microvesicles (ARMMs)
|
|
CA2970683A1
(en)
|
2014-12-18 |
2016-06-23 |
Integrated Dna Technologies, Inc. |
Crispr-based compositions and methods of use
|
|
WO2016105518A1
(en)
*
|
2014-12-23 |
2016-06-30 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce targeted protein degradation through bifunctional molecules
|
|
US9694084B2
(en)
|
2014-12-23 |
2017-07-04 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce targeted protein degradation through bifunctional molecules
|
|
US9650617B2
(en)
|
2015-01-28 |
2017-05-16 |
Pioneer Hi-Bred International. Inc. |
CRISPR hybrid DNA/RNA polynucleotides and methods of use
|
|
US9790490B2
(en)
|
2015-06-18 |
2017-10-17 |
The Broad Institute Inc. |
CRISPR enzymes and systems
|
|
US10059741B2
(en)
|
2015-07-01 |
2018-08-28 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
EP3317294B1
(en)
|
2015-07-02 |
2023-03-15 |
Dana-Farber Cancer Institute, Inc. |
Stabilized anti-microbial peptides
|
|
US10772962B2
(en)
*
|
2015-08-19 |
2020-09-15 |
Arvinas Operations, Inc. |
Compounds and methods for the targeted degradation of bromodomain-containing proteins
|
|
US20190002506A1
(en)
*
|
2015-08-28 |
2019-01-03 |
Dana-Farber Cancer Institute, Inc. |
Stabilized peptides for covalent binding to target protein
|
|
CA2995479A1
(en)
*
|
2015-08-28 |
2017-03-09 |
Dana-Farber Cancer Institute, Inc. |
Peptides binding to bfl-1
|
|
CA3014442A1
(en)
|
2016-02-29 |
2017-09-08 |
Dana-Farber Cancer Institute, Inc. |
Stapled intracellular-targeting antimicrobial peptides to treat infection
|
|
US20190076504A1
(en)
|
2016-03-23 |
2019-03-14 |
Dana-Farber Cancer Institute, Inc. |
COMPOSITIONS, ASSAYS, AND METHODS FOR TARGETING HDM2 AND HDMX TO REVERSE THE INHIBITION OF p53 IN PEDIATRIC CANCERS
|
|
CN118436801A
(zh)
*
|
2016-05-20 |
2024-08-06 |
豪夫迈·罗氏有限公司 |
Protac抗体缀合物及其使用方法
|